Veeva Expands Partnership with Roche Pharmaceuticals
Veeva Systems (NYSE: VEEV) has recently announced an exciting expansion of their collaboration with Roche Pharmaceuticals. By adopting Veeva Vault CRM, Roche aims to transform its customer engagement strategies with the help of agentic AI technology.
Addressing Future Needs in Pharma
According to Veeva CEO Peter Gassner, the longstanding partnership between Roche and Veeva has been characterized by mutual growth and innovation. "We are honored to extend our partnership to Vault CRM and bring the next generation of AI-enabled CRM to the global Roche Pharma field teams," Gassner stated. This collaboration demonstrates Veeva's commitment to supporting the evolving needs of the pharmaceutical industry.
Enhancing Customer Interactions
Wafaa Mamilli, Roche's chief digital and technology officer, expressed enthusiasm about implementing Vault CRM across Roche's global Pharma organization. She emphasized that with data and AI at its core, Vault CRM will enable Roche to create more personalized interactions. This transformation will empower Roche's teams with the insights needed to better support healthcare professionals and the patients they serve.
The Power of Vault CRM Suite
Vault CRM is an integral part of the Vault CRM Suite, which lays a strong foundation for effective commercial execution. The suite includes Veeva AI, a cutting-edge AI technology that enhances various applications within the Vault platform. The upcoming Veeva AI Agents for Vault CRM, including the Free Text Agent, Voice Agent, Pre-call Agent, and Media Agent, are expected to be launched in December 2025. These advancements promise to take customer engagement to new heights.
About Veeva Systems
Veeva Systems is at the forefront of delivering industry-specific cloud solutions for the life sciences sector. With an unwavering dedication to innovation and excellence, Veeva serves over 1,500 customers worldwide, ranging from major biopharmaceutical companies to budding biotechs. As a Public Benefit Corporation, Veeva is devoted to balancing the interests of its diverse stakeholders, reinforcing their commitment to customer success.
Staying Ahead in Innovation
Veeva’s core philosophy emphasizes the importance of continual innovation. The company stands firm in its mission to deliver cutting-edge products and services that meet the unique needs of the life sciences industry. By proactively addressing the challenges posed by modern healthcare demands, Veeva is striving to shape the future of patient care through technology.
Frequently Asked Questions
What is the purpose of Veeva’s partnership with Roche?
The partnership aims to implement Veeva Vault CRM for enhancing customer engagement and personalized interactions in Roche's Pharma operations.
What are the upcoming features of Veeva Vault CRM?
Veeva Vault CRM will feature various AI agents, including Free Text Agent and Voice Agent, planned for release in December 2025.
How long have Veeva and Roche been partners?
Veeva and Roche have enjoyed a long-standing partnership, collaborating on numerous projects focused on advancing pharmaceutical innovation.
What industries does Veeva serve?
Veeva primarily serves the life sciences industry, encompassing both biopharmaceutical companies and emerging biotech firms.
What is Veeva's commitment to stakeholders?
Veeva is dedicated to balancing the interests of all stakeholders, including customers, employees, and shareholders, while driving industry innovation.
